Archived article
Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.
Omega Diagnostics Group PLC - Alva, Scotland-based diagnostics company - Receives a deferred consideration of £4.0 million relating to the sale of its CD4 business.
In August, Omega sold its CD4-focused Global Health division for £6.1 million to Accubio Ltd, a wholly-owned subsidiary of Chinese biotechnology firm Zhejiang Orient Gene Biotech Co Ltd.
Current stock price: 4.08 pence, up 13% on Friday
12-month change: down 86%
Copyright 2022 Alliance News Limited. All Rights Reserved.